Stay updated on Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-12T19:42:16.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; the new revision notice shows Revision: v3.4.2 and replaces the previous Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-12T02:45:10.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Footer/site revision updated from v3.4.0 to v3.4.1; no changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T22:31:19.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Show glossary feature added; page metadata labels updated (Last Update Submitted that Met QC Criteria and No FEAR Act Data); revision bumped to v3.4.0. These are UI/metadata refinements and do not alter core study information, eligibility criteria, endpoints, or results.
    Difference
    0.1%
    Check dated 2026-01-28T21:26:55.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added and Revision: v3.3.3 removed as part of a backend update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:09:39.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Adds an extensive, international list of enrollment locations across the US, Australia, and other regions, detailing cities and regions where the trial is conducted. This clarifies the geographic scope for recruitment and helps potential participants find eligible sites.
    Difference
    3%
    Check dated 2025-12-23T21:07:10.000Z thumbnail image

Stay in the know with updates to Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.